Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
Sign Up to like & getrecommendations! Published in 2019 at "International Journal for Parasitology: Drugs and Drug Resistance"
DOI: 10.1016/j.ijpddr.2019.09.004
Abstract: Background Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B… read more here.
Keywords: cutaneous leishmaniasis; treatment; lip amb; amb ... See more keywords